Global immune disregulation in multiple sclerosis: From the adaptive response to the innate immunity

Giovanni Ristori, Chiara Montesperelli, Alessia Perna, Stefania Cannoni, Luca Battistini, Giovanna Borsellino, Paolo Riccio, Graziano Pesole, Alberto Chersi, Carlo Pozzilli, Carla Buttinelli, Marco Salvetti

Research output: Contribution to journalArticlepeer-review

Abstract

Increasing evidences show a global immune disregulation in multiple sclerosis (MS). The possible involvement of myelin and non-myelin (auto- )antigens in the autoaggressive process as well as the disregulation of both adaptive and innate immunity challenge the concept of specific immunotherapy. T cells at the boundary between innate and adaptive immunity, whose immunoregulatory role is becoming increasingly clear, have recently been shown to bear relevance for MS pathogenesis. Global immune interventions (and type I interferons may be considered as such) aimed at interfering with both innate and acquired immune responses seem to be a most promising therapeutic option in MS. (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)216-219
Number of pages4
JournalJournal of Neuroimmunology
Volume107
Issue number2
DOIs
Publication statusPublished - Jul 24 2000

Keywords

  • Immunity
  • Multiple sclerosis
  • T cells

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Fingerprint Dive into the research topics of 'Global immune disregulation in multiple sclerosis: From the adaptive response to the innate immunity'. Together they form a unique fingerprint.

Cite this